Results showed that reduction of LUZP1 expression led to weakened proliferation, migration and invasion abilities in OS cells and weakened tube formation capabilities in HUVEC (Fig. S9E-L), indicated that LUZP1 was the target of circFIRRE that affected tumor growth, lung metastasis and angiogenesis. The gene discussed is LUZP1; the disease is neoplasm.